CV Sciences (CVSI) Depreciation & Amortization (CF) (2013 - 2026)
CV Sciences' (CVSI) quarterly Depreciation & Amortization (CF) came in at $23000.0 in Q1 2026, down 71.95% year-on-year from $82000.0 in Q1 2025, and up 9.52% quarter-over-quarter from $21000.0 in Q4 2025.
CV Sciences (CVSI) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Depreciation & Amortization (CF) across 14 years of filings, most recently posting $23000.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $23000.0, down 71.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $133000.0 (down 62.32% YoY), and the FY2025 annual result was $192000.0, down 42.51% from the prior year.
- Depreciation & Amortization (CF) came in at $23000.0 for Q1 2026 at CV Sciences, up from $21000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $517000.0 in Q1 2022 to a low of $21000.0 in Q4 2025.
- The 5-year median for Depreciation & Amortization (CF) is $63000.0 (2022), against an average of $104470.6.
- Across the five-year window, Depreciation & Amortization (CF) surged 153.43% in 2022 and sank 88.59% in 2023, its largest moves.
- CV Sciences' Depreciation & Amortization (CF) stood at $69000.0 in 2022, then fell by 14.49% to $59000.0 in 2023, then jumped by 93.22% to $114000.0 in 2024, then tumbled by 81.58% to $21000.0 in 2025, then gained by 9.52% to $23000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $23000.0 (Q1 2026), $21000.0 (Q4 2025), and $31000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |